Indian Pharma Firm Linked to West Africa's Growing Opioid Crisis
An investigation by BBC Eye has uncovered that Aveo Pharmaceuticals, a Mumbai-based company, is producing and illegally exporting unlicensed and highly addictive opioids to West Africa, exacerbating a public health crisis in countries such as Ghana, Nigeria, and Côte d'Ivoire. The drugs, notably a dangerous combination of tapentadol and carisoprodol, are being marketed under various brand names, including Tafrodol, and are available cheaply on the streets.
The BBC's undercover investigation revealed factory footage of Aveo's director, Vinod Sharma, acknowledging the harmful effects of these drugs but candidly referring to the trade as "business." These opioids are reportedly popular among teenagers who misuse them alongside alcoholic energy drinks to enhance their effects, raising concerns about rising addiction rates in the region.
Officials like Brig Gen Mohammed Buba Marwa of Nigeria's Drug and Law Enforcement Agency noted that opioids are wreaking havoc on families and communities. Amidst increasing scrutiny, Indian pharmacological regulations are reportedly being violated, putting at risk the integrity of India's broader pharmaceutical reputation, which supplies essential medicines globally.
